The patent covers compositions and methods of formulating using XORTX’s proprietary formulations of xanthine oxidase inhibitors (“XOI”) for the treatment of health consequences of ...

Xanthine oxidase inhibitors treatment and mortality The number of patients with each XOI prescription was following: 64,801 allopurinol, 252,002 febuxostat, and 4,341 topiroxostat. The mortality of ...

This degree of urate lowering compares favorably to that seen with optimal treatment with other xanthine oxidase inhibitors such as allopurinol and febuxostat (Uloric). Efficacy did not seem ...

It has a different structure from other xanthine oxidase inhibitors such as the purine analog xanthine oxidase inhibitor, allopurinol.

Tigulixostat is a novel xanthine oxidase inhibitor targeting the reduction of uric acid in purine metabolism, by inhibiting the activity of xanthine oxidase. It has a different structure from other ...

It has a different structure from other xanthine oxidase inhibitors such as the purine analog xanthine oxidase inhibitor, allopurinol.

Tigulixostat is a novel xanthine oxidase inhibitor targeting the reduction of uric acid in purine metabolism, by inhibiting the activity of xanthine oxidase. It has a different structure from other ...